Treatment
Treatment
04/24/2017
The FDA has approved a new indication for the drug Thymoglobulin, for use in patients undergoing kidney transplant.
04/24/2017
FDA
FDA
04/24/2017
The US Food and Drug Administration recently approved the second biosimilar to Remicade for the treatment of immune-disorders.
04/24/2017
FDA
FDA
04/24/2017
The US Food and Drug Administration recently approved the second biosimilar to Remicade for the treatment of immune-disorders.
04/24/2017
FDA
FDA
04/24/2017
The US Food and Drug Administration recently approved the second biosimilar to Remicade for the treatment of immune-disorders.
04/24/2017
bladder
bladder
04/18/2017
The FDA has approved the first and only cancer immunotherapy for the initial treatment of certain bladder cancers.
04/18/2017
bladder
bladder
04/18/2017
The FDA has approved the first and only cancer immunotherapy for the initial treatment of certain bladder cancers.
04/18/2017
bladder
bladder
04/18/2017
The FDA has approved the first and only cancer immunotherapy for the initial treatment of certain bladder cancers.
04/18/2017
Diabetic Retinopathy
Diabetic Retinopathy
04/17/2017
The FDA has approved the first and only option for the treatment of all forms of diabetic retinopathy.
04/17/2017
Diabetic Retinopathy
Diabetic Retinopathy
04/17/2017
The FDA has approved the first and only option for the treatment of all forms of diabetic retinopathy.
04/17/2017
Diabetic Retinopathy
Diabetic Retinopathy
04/17/2017
The FDA has approved the first and only option for the treatment of all forms of diabetic retinopathy.
04/17/2017